Jeffery Scott Magnuson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jeffery Scott Magnuson has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Costantino
Otorhinolaryngology Unit IRCCS Humanitas Research Hospital Milan Italy
8 shared publications Uthman Alamoudi
Department of Otolaryngology – Head and Neck Surgery AdventHealth Orlando Orlando Florida USA
6 shared publicationsAndrea Costantino
Otorhinolaryngology Unit, IRCCS Humanitas Research Hospital, Via Manni zo56, Milan, Rozzano 20089, Italy; Department of Otolaryngology - Head and Neck Surgery, AdventHealth Orlando, 410 Celebration Place, Celebration, FL 34747, United States
5 shared publicationsBruce H. Haughey
Department of Otolaryngology - Head and Neck Surgery, AdventHealth Orlando, 410 Celebration Place, Celebration, FL 34747, United States; Department of Otolaryngology - Head and Neck Surgery, University of South Florida Morsani College of Medicine, Tampa, FL, United States; Department of Surgery, University of Auckland School of Medicine and Allied Health Sciences, Auckland, New Zealand
3 shared publications- Bruce H. Haughey
Department of Otolaryngology—Head and Neck Surgery AdventHealth Orlando Orlando Florida USA
3 shared publications Bruce Haughey
Department of Otolaryngology—Head and Neck Surgery AdventHealth Orlando Orlando Florida USA
3 shared publications
Latest Publications
- 30 October 2026
- Published by Wiley in Head & Neck
Laser‐Assisted Transoral Robotic Supraglottic Laryngectomy
Objective: To describe the operative setup, safety principles, and stepwise technique for laser‐assisted transoral robotic supraglottic laryngectomy using a flexible CO 2 laser system. Methods: This operative video demonstrates laser‐assisted transoral robotic supraglottic laryngectomy performed with the da Vinci SP platform. Key technical steps include laser‐safe airway management, transoral exposure with a Feyh–Kastenbauer retractor, robotic docking, flexible CO 2 laser fiber placement through a distal drop‐in guide, aiming‐beam confirmation, noncontact laser dissection, coordinated bedside suction and bipolar hemostasis, and en bloc specimen delivery. Results: The technique allows controlled transoral access to the supraglottic larynx with three‐dimensional visualization, precise noncontact laser incision, and preservation of uninvolved glottic and subglottic structures. A deliberate sequence of inferior, lateral, and superior release facilitates exposure of the pre‐epiglottic space, specimen mobilization, and margin‐oriented en bloc resection. Conclusion: Laser‐assisted transoral robotic supraglottic laryngectomy combines the precision of CO 2 laser surgery with the visualization and dexterity of single‐port robotic surgery. With appropriate patient selection, strict laser safety, and a standardized team‐based workflow, this technique can support precise en bloc resection, reliable margin assessment, and preservation of uninvolved laryngeal structures.
- 30 October 2026
- Published by Wiley in Head & Neck
Laser‐Assisted Transoral Robotic Supraglottic Laryngectomy
Objective: To describe the operative setup, safety principles, and stepwise technique for laser‐assisted transoral robotic supraglottic laryngectomy using a flexible CO 2 laser system. Methods: This operative video demonstrates laser‐assisted transoral robotic supraglottic laryngectomy performed with the da Vinci SP platform. Key technical steps include laser‐safe airway management, transoral exposure with a Feyh–Kastenbauer retractor, robotic docking, flexible CO 2 laser fiber placement through a distal drop‐in guide, aiming‐beam confirmation, noncontact laser dissection, coordinated bedside suction and bipolar hemostasis, and en bloc specimen delivery. Results: The technique allows controlled transoral access to the supraglottic larynx with three‐dimensional visualization, precise noncontact laser incision, and preservation of uninvolved glottic and subglottic structures. A deliberate sequence of inferior, lateral, and superior release facilitates exposure of the pre‐epiglottic space, specimen mobilization, and margin‐oriented en bloc resection. Conclusion: Laser‐assisted transoral robotic supraglottic laryngectomy combines the precision of CO 2 laser surgery with the visualization and dexterity of single‐port robotic surgery. With appropriate patient selection, strict laser safety, and a standardized team‐based workflow, this technique can support precise en bloc resection, reliable margin assessment, and preservation of uninvolved laryngeal structures.
- 18 August 2026
- Published by Wiley in Clinical Otolaryngology
- Vol. 51 (6) , 952-959
Predictors of Enrolment in a Transoral Surgical Trial for HPV ‐Related Oropharyngeal Carcinoma
Objective: This study evaluated demographic, clinical and perceptual factors associated with enrolment in a Phase III transoral surgical trial for HPV‐related oropharyngeal carcinoma. Design: Single‐centre, questionnaire‐based cross‐sectional pilot study of patients screened for PATHOS trial. Setting: Tertiary cancer centre participating in the PATHOS trial. Participants: Patients with p16‐positive oropharyngeal carcinoma were eligible for the trial. Of 100 patients screened, 70 met trial eligibility and 51 completed a telephone questionnaire and were included. Inability to complete the questionnaire because of cognitive impairment or a language barrier was a prespecified survey exclusion criterion. However, no patient was excluded for either reason. Main Outcome Measures: Primary outcome was the patient decision to enrol or decline participation in PATHOS (written consent). Predictor variables included demographic and clinical characteristics and responses to a 31‐item Likert‐scale questionnaire. Results: Among 51 eligible patients who completed the questionnaire, 29 (57%) enroled in the trial. On univariable analysis, significant predictors included perceptions of treatment quality, toxicity, quality of life, travel distance, trial comprehension, randomisation, medical terminology, trust, prior trial experience and concern about being treated as a ‘guinea pig’. On multivariable analysis, prior trial experience ( p = 0.022) and not feeling like a ‘guinea pig’ ( p = 0.047) remained significant, with travel distance trending ( p = 0.087). Conclusions: Trial enrolment was driven primarily by prior exposure to clinical research and perceptions of vulnerability and trust, rather than by demographic or tumour factors. Addressing fears of being a ‘guinea pig’, improving trial comprehension and mitigating travel‐related barriers may enhance accrual and promote more equitable participation in head and neck cancer trials.
- 18 August 2026
- Published by Wiley in Clinical Otolaryngology
- Vol. 51 (6) , 952-959
Predictors of Enrolment in a Transoral Surgical Trial for HPV ‐Related Oropharyngeal Carcinoma
Objective: This study evaluated demographic, clinical and perceptual factors associated with enrolment in a Phase III transoral surgical trial for HPV‐related oropharyngeal carcinoma. Design: Single‐centre, questionnaire‐based cross‐sectional pilot study of patients screened for PATHOS trial. Setting: Tertiary cancer centre participating in the PATHOS trial. Participants: Patients with p16‐positive oropharyngeal carcinoma were eligible for the trial. Of 100 patients screened, 70 met trial eligibility and 51 completed a telephone questionnaire and were included. Inability to complete the questionnaire because of cognitive impairment or a language barrier was a prespecified survey exclusion criterion. However, no patient was excluded for either reason. Main Outcome Measures: Primary outcome was the patient decision to enrol or decline participation in PATHOS (written consent). Predictor variables included demographic and clinical characteristics and responses to a 31‐item Likert‐scale questionnaire. Results: Among 51 eligible patients who completed the questionnaire, 29 (57%) enroled in the trial. On univariable analysis, significant predictors included perceptions of treatment quality, toxicity, quality of life, travel distance, trial comprehension, randomisation, medical terminology, trust, prior trial experience and concern about being treated as a ‘guinea pig’. On multivariable analysis, prior trial experience ( p = 0.022) and not feeling like a ‘guinea pig’ ( p = 0.047) remained significant, with travel distance trending ( p = 0.087). Conclusions: Trial enrolment was driven primarily by prior exposure to clinical research and perceptions of vulnerability and trust, rather than by demographic or tumour factors. Addressing fears of being a ‘guinea pig’, improving trial comprehension and mitigating travel‐related barriers may enhance accrual and promote more equitable participation in head and neck cancer trials.
- 21 May 2026
- Published by Elsevier in Oral Oncology
- Vol. 179, 108024
Optimizing adjuvant therapy selection with machine learning after transoral surgery in HPV-related oropharyngeal cancer
- 21 May 2026
- Published by Elsevier in Oral Oncology
- Vol. 179, 108024
Optimizing adjuvant therapy selection with machine learning after transoral surgery in HPV-related oropharyngeal cancer
- 11 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1-6
Initial clinical experience with the da Vinci 5 in transoral robotic surgery
To describe early clinical experience using the multi-port da Vinci 5 (DV5) system for transoral robotic surgery (TORS) reporting perioperative outcomes. W
- 11 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 20 (1) , 1-6
Initial clinical experience with the da Vinci 5 in transoral robotic surgery
To describe early clinical experience using the multi-port da Vinci 5 (DV5) system for transoral robotic surgery (TORS) reporting perioperative outcomes. W
- 12 September 2025
- Published by Wiley in Head & Neck
- Vol. 48 (2) , 457-467
Predictive Nomogram for Risk Stratification After Transoral Surgery in HPV ‐Related Oropharyngeal Cancer
Background: This study develops a predictive model that stratifies patients with HPV‐related oropharyngeal squamous cell carcinoma (OPSCC) by survival outcomes based on adjuvant treatment received following transoral surgery (TOS). Methods: Patients receiving primary TOS with or without adjuvant were included from the National Cancer Database. A predictive nomogram was constructed using a multivariable Cox regression model. Results: A total of 5569 patients were included. The model based on 11 demographic, socioeconomic, and clinical variables stratified patients into low‐risk (57%), intermediate‐risk (35.5%), and high‐risk (7.5%) cohorts, with significant differences in survival between the risk groups. No association with better survival was found for adjuvant treatment in the low‐risk group. A significant association between adjuvant treatment and improved survival was measured in the intermediate‐risk and high‐risk cohorts. Conclusions: This predictive model effectively stratified OPSCC patients by risk, revealing outcome differences based on adjuvant treatment. Further studies are required to validate these findings.
- 12 September 2025
- Published by Wiley in Head & Neck
- Vol. 48 (2) , 457-467
Predictive Nomogram for Risk Stratification After Transoral Surgery in HPV ‐Related Oropharyngeal Cancer
Background: This study develops a predictive model that stratifies patients with HPV‐related oropharyngeal squamous cell carcinoma (OPSCC) by survival outcomes based on adjuvant treatment received following transoral surgery (TOS). Methods: Patients receiving primary TOS with or without adjuvant were included from the National Cancer Database. A predictive nomogram was constructed using a multivariable Cox regression model. Results: A total of 5569 patients were included. The model based on 11 demographic, socioeconomic, and clinical variables stratified patients into low‐risk (57%), intermediate‐risk (35.5%), and high‐risk (7.5%) cohorts, with significant differences in survival between the risk groups. No association with better survival was found for adjuvant treatment in the low‐risk group. A significant association between adjuvant treatment and improved survival was measured in the intermediate‐risk and high‐risk cohorts. Conclusions: This predictive model effectively stratified OPSCC patients by risk, revealing outcome differences based on adjuvant treatment. Further studies are required to validate these findings.
- 30 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 63-75
Outcomes of Free Flap Bony Reconstruction for Maxillary Defects: A Systematic Review and Meta‐Analysis
Objective: To analyze the clinical outcomes associated with free flap bony reconstruction of maxillary defects. Data Sources: A systematic search was performed on PubMed, Scopus, and Google Scholar databases. Review Methods: A single‐arm meta‐analysis of proportions was performed to calculate the pooled effect size. The inverse variance method was used to combine the effect sizes from individual studies and calculate the 95% confidence interval (CI). Results: A total of 837 patients undergoing scapula (35.1%), fibula (37.3%), iliac crest (15.4%), and radial forearm (12.2%) reconstruction were included. The pooled flap success rate was 93.0% (95% CI: 90.6–94.9). A low fistula rate (15.9%; 95% CI: 12.8–19.6) and a high speech intelligibility rate (91.2%; 95% CI: 86.9–94.2) were measured. The pooled unrestricted diet rate was 81.2% (95% CI: 69.6–89.0), while the pooled dental implant rate was 23.5% (95% CI: 12.0–40.9). Scapula (13.6%, 95% CI: 5.2–31.2) showed a lower dental implant rate compared to fibula (33.4%, 95% CI: 6.1–79.6) and iliac crest (37.1%, 95% CI: 23.0–53.7) flaps. None of the patients with radial forearm flap received dental implants. No significant differences were found between flaps for the other outcomes. Conclusions: Free flap bony reconstruction for maxillary defects is a reliable approach achieving excellent speech intelligibility and low fistula rates. Although the rates of unrestricted dietary intake were encouraging, dental implant placement remains a significant area for improvement. Level of Evidence: NA.
- 30 July 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (1) , 63-75
Outcomes of Free Flap Bony Reconstruction for Maxillary Defects: A Systematic Review and Meta‐Analysis
Objective: To analyze the clinical outcomes associated with free flap bony reconstruction of maxillary defects. Data Sources: A systematic search was performed on PubMed, Scopus, and Google Scholar databases. Review Methods: A single‐arm meta‐analysis of proportions was performed to calculate the pooled effect size. The inverse variance method was used to combine the effect sizes from individual studies and calculate the 95% confidence interval (CI). Results: A total of 837 patients undergoing scapula (35.1%), fibula (37.3%), iliac crest (15.4%), and radial forearm (12.2%) reconstruction were included. The pooled flap success rate was 93.0% (95% CI: 90.6–94.9). A low fistula rate (15.9%; 95% CI: 12.8–19.6) and a high speech intelligibility rate (91.2%; 95% CI: 86.9–94.2) were measured. The pooled unrestricted diet rate was 81.2% (95% CI: 69.6–89.0), while the pooled dental implant rate was 23.5% (95% CI: 12.0–40.9). Scapula (13.6%, 95% CI: 5.2–31.2) showed a lower dental implant rate compared to fibula (33.4%, 95% CI: 6.1–79.6) and iliac crest (37.1%, 95% CI: 23.0–53.7) flaps. None of the patients with radial forearm flap received dental implants. No significant differences were found between flaps for the other outcomes. Conclusions: Free flap bony reconstruction for maxillary defects is a reliable approach achieving excellent speech intelligibility and low fistula rates. Although the rates of unrestricted dietary intake were encouraging, dental implant placement remains a significant area for improvement. Level of Evidence: NA.
- 14 July 2025
- Published by Wiley in Head & Neck
- Vol. 47 (12) , 3275-3284
Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
Objective: The aim of this study is to analyze the impact of extranodal extension (ENE) on survival outcomes for patients with metastatic cutaneous head and neck squamous cell carcinoma (cHNSCC). Methods: The pooled hazard ratios (HRs) and the 95% confidence interval (CI) were calculated to define the impact of ENE on overall survival (OS) and disease‐free survival (DFS). Results: A total of 2076 patients (males: 84.4%) with a median age of 73.3 years were included. The incidence of ENE was 65.6% ( N = 1299/1979). The median follow‐up time was 38.4 months (95% CI: 21–38.4). The estimated pooled HRs were 1.31 (95% CI: 0.72–2.39; p = 0.28) and 1.80 (95% CI: 0.53–6.10; p = 0.22) for OS and DFS, respectively. Conclusions: ENE may not be a reliable prognostic factor in metastatic cHNSCC. Further prospective studies are needed to refine risk stratification and improve the current nodal classification system.
- 14 July 2025
- Published by Wiley in Head & Neck
- Vol. 47 (12) , 3275-3284
Impact of Extranodal Extension in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta‐Analysis
Objective: The aim of this study is to analyze the impact of extranodal extension (ENE) on survival outcomes for patients with metastatic cutaneous head and neck squamous cell carcinoma (cHNSCC). Methods: The pooled hazard ratios (HRs) and the 95% confidence interval (CI) were calculated to define the impact of ENE on overall survival (OS) and disease‐free survival (DFS). Results: A total of 2076 patients (males: 84.4%) with a median age of 73.3 years were included. The incidence of ENE was 65.6% ( N = 1299/1979). The median follow‐up time was 38.4 months (95% CI: 21–38.4). The estimated pooled HRs were 1.31 (95% CI: 0.72–2.39; p = 0.28) and 1.80 (95% CI: 0.53–6.10; p = 0.22) for OS and DFS, respectively. Conclusions: ENE may not be a reliable prognostic factor in metastatic cHNSCC. Further prospective studies are needed to refine risk stratification and improve the current nodal classification system.
- 8 May 2025
- Published by Elsevier in Oral Oncology
- Vol. 165, 107361
Prognostic significance of distant metastasis site at diagnosis in HPV-related oropharyngeal cancer
- 8 May 2025
- Published by Elsevier in Oral Oncology
- Vol. 165, 107361
Prognostic significance of distant metastasis site at diagnosis in HPV-related oropharyngeal cancer
- 18 April 2025
- Published by Elsevier in Oral Oncology
- Vol. 165, 107312
Adjuvant treatment in elderly patients undergoing transoral surgery for HPV-related oropharyngeal cancer
- 18 April 2025
- Published by Elsevier in Oral Oncology
- Vol. 165, 107312
Adjuvant treatment in elderly patients undergoing transoral surgery for HPV-related oropharyngeal cancer
- 7 February 2025
- Published by Wiley in Head & Neck
- Vol. 47 (7) , 1867-1877
Transoral Surgery Versus Radiotherapy as Primary Treatment for HPV‐Related Oropharyngeal Cancer in the Elderly
Background: This study compares the oncological outcomes of primary transoral surgery (TOS) and primary radiotherapy (RT) in elderly patients with HPV‐related oropharyngeal squamous cell carcinoma (OPSCC).Methods: This retrospective cohort study included patients with cT1‐2 HPV‐related OPSCC from the National Cancer Database (NCDB).Results: A total of 2566 patients were included, with 73.9% receiving primary RT and 22.3% undergoing primary TOS. Subgroup analysis showed a higher 5‐year overall survival (OS) rate for primary TOS (81.6%; 95% CI: 79.6%–83.6%) compared to primary RT (70.7%; 95% CI: 68.3%–73.1%), with an adjusted hazard ratio (HR) of 0.64 (95% CI: 0.50–0.81; p < 0.001) after propensity score matching. Notably, only (13.6%) of patients diagnosed in 2020 underwent primary TOS, with a significant decline over the study period.Conclusions: This study suggests that primary TOS may offer better survival outcomes for elderly patients with HPV‐related OPSCC compared to primary RT.
- 7 February 2025
- Published by Wiley in Head & Neck
- Vol. 47 (7) , 1867-1877
Transoral Surgery Versus Radiotherapy as Primary Treatment for HPV‐Related Oropharyngeal Cancer in the Elderly
Background: This study compares the oncological outcomes of primary transoral surgery (TOS) and primary radiotherapy (RT) in elderly patients with HPV‐related oropharyngeal squamous cell carcinoma (OPSCC).Methods: This retrospective cohort study included patients with cT1‐2 HPV‐related OPSCC from the National Cancer Database (NCDB).Results: A total of 2566 patients were included, with 73.9% receiving primary RT and 22.3% undergoing primary TOS. Subgroup analysis showed a higher 5‐year overall survival (OS) rate for primary TOS (81.6%; 95% CI: 79.6%–83.6%) compared to primary RT (70.7%; 95% CI: 68.3%–73.1%), with an adjusted hazard ratio (HR) of 0.64 (95% CI: 0.50–0.81; p < 0.001) after propensity score matching. Notably, only (13.6%) of patients diagnosed in 2020 underwent primary TOS, with a significant decline over the study period.Conclusions: This study suggests that primary TOS may offer better survival outcomes for elderly patients with HPV‐related OPSCC compared to primary RT.